AGM
BDSX icon

Alpine Global Management’s Biodesix BDSX Stock Holding History

Alpine Global Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-799
Closed -$24.4K – 143
2024
Q4 		$24.4K Buy
+799
New +$23.5K 0.01% 165

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Alpine Global Management's BDSX Position: Q1 2025 in Review

Alpine Global Management sold out of Biodesix (BDSX) in Q1 2025, closing a stake of 799 shares — an estimated $24.4K sold.

Alpine Global Management first reported a position in BDSX in Q4 2024 and held it in 1 quarter. The position peaked at $24.4K in Q4 2024. 59 funds tracked by Wall St. Rank hold BDSX as of Q1 2025.

  • Alpine Global Management reported no remaining Biodesix position as of Q1 2025 after selling out during the quarter.
  • Alpine Global Management sold 799 Biodesix shares in Q1 2025, an estimated $24.4K.
  • Alpine Global Management first reported a position in Biodesix in Q4 2024 and held it in 1 quarter.
  • Alpine Global Management's Biodesix position peaked at $24.4K in Q4 2024.
  • 59 funds tracked by Wall St. Rank held Biodesix as of Q1 2025.

Based on Alpine Global Management's 13F filing for Q1 2025, filed 15 May 2025.